Spinal Cord Injury: Immunotherapy Recovery Boost
- A new study from Washington University School of Medicine in St.
- Jonathan Kipnis, a professor of pathology and immunology at WashU Medicine, noted the common perception of immune cells as detrimental to the central nervous system.
- Wenqing Gao, a postdoctoral research associate, analyzed T cells from injured mice spinal cords to differentiate between harmful and protective cells.
Immunotherapy gets a boost in spinal cord injury recovery, according to a groundbreaking study. Researchers discovered that modified T cells can protect neurons from immune cell attacks, leading to improved mobility in mice. This marks a significant step toward minimizing damage after traumatic spinal cord injuries, a leading cause of lasting disabilities. By harnessing the neuroprotective functions of immune cells,this innovative approach offers hope where effective treatments have been scarce. The team is preparing to launch clinical trials, potentially offering new options for patients. Furthermore, they plan to extend their research into neurodegenerative diseases. News Directory 3 is following this story.Discover what’s next for this exciting therapeutic avenue.
Immunotherapy Shows Promise in Spinal Cord Injury Recovery
Updated June 11, 2025
A new study from Washington University School of Medicine in St. Louis suggests that immunotherapy may minimize damage following traumatic spinal cord injury. The research, published in Nature, details how the therapy protected neurons from immune cell attacks in mice, leading to improved mobility.Spinal cord injuries, a leading cause of lasting disabilities, frequently enough result in damage beyond the initial trauma.
Jonathan Kipnis, a professor of pathology and immunology at WashU Medicine, noted the common perception of immune cells as detrimental to the central nervous system. However, he said this study demonstrates the potential to harness the neuroprotective functions of these cells to aid recovery from spinal cord injury.
Wenqing Gao, a postdoctoral research associate, analyzed T cells from injured mice spinal cords to differentiate between harmful and protective cells. The goal was to replicate the beneficial cells for treatment. Gao modified the protective T cells to deactivate after a few days, preventing autoimmune reactions. Mice treated with these modified T cells showed improved mobility, particularly when the cells were administered within a week of the injury. no autoimmune reactions were observed.
Gao emphasized the lack of effective treatments for central nervous system injuries. She said this immunotherapy approach, leveraging protective immune cells, significantly improved mobility in mice.
The researchers, in collaboration with Dr. Wilson Zachary Ray, also found an expansion of T cells in the cerebral spinal fluid of patients with spinal cord injuries, suggesting the feasibility of generating immunotherapy from a patient’s own cells.
Gao said the next step is to develop a clinical trial to test the immunotherapy in people with spinal cord injuries. The team also plans to expand the research to neurodegenerative diseases like ALS, Alzheimer’s, and Parkinson’s, exploring the potential of adapting the engineered cells for broader therapeutic use in spinal cord injury and other neurodegenerative diseases.
“immune cells in the central nervous system have a reputation for being the bad guys that can harm the brain and spinal cord,” said Jonathan Kipnis.”But our study shows that it’s possible to take advantage of immune cells’ neuroprotective function…to help in the recovery from central nervous system injury.”
What’s next
researchers are planning clinical trials to test the immunotherapy in humans with spinal cord injuries and explore its potential submission in neurodegenerative diseases.